How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary
A new plain language summary of publication published in Future Cardiology summarises some of the results of a study called ATTR-ACT. The article looked at the participants of the study who took placebo to learn how transthyretin amyloid cardiomyopathy progressed without treatment.
Read the article in full here.
Click here to read the original article on which this summary is based.